Saito M, Seo Y, Yano Y, Uehara K, Hara S, Momose K, Hirano H, Yokozaki H, Yoshida M, Azuma T

Idioma: Ingles.
Referencias bibliográficas: 19
Paginas: 969-973
Archivo PDF: 195.00 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, Nakanuma Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004; 101: 796-802.

2. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006; 243: 229- 35.

3. Ikai I, Arii S, Ichida T, Okita K, Omata M, Kojiro M, Takayasu K, et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 2005; 32: 163-72.

4. Chen JS, Wang Q, Chen XL, Huang XH, Liang LJ, Lei J, Huang JQ, et al. Clinicopathological characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis. J Surg Res 2012; 175: 243-50.

5. Jia L, Kiryu S, Watadani T, Akai H, Yamashita H, Akahane M, Ohtomo K. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus: assessment based on clinical and computer tomography characteristics. Acta Med Okayama 2012; 66: 131-41.

6. Qi X, Han G, He C, Yin Z, Guo W, Niu J, Fan D. CT feature of non-malignant portal vein thrombosis: a pictorial review. Clin Res Hepatol Gastroenterol 2012; 36: 561-8.

7. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000; 32: 865-71.

8. De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med 2010; 5: 487-94.

9. Lertpipopmetha K, Auewarakul CU. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the southwest asian patients with portal vein thrombosis. BMC Gastroenterol 2011; 11: 66.

10. Arii S, Tanaka J, Yamazoe Y, Minematsu S, Morino T, Fujita K, Maetani S, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992; 69: 913-9.

11. Kojiro M. Pathology of hepatocellular carcinoma. Oxford: Blackwell Publishing; 2006, p. 63-75.

12. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine leaning. Nat Med 2003; 9: 416-23.

13. Shuqun C, Mengchao W, Han C, Feng S, Jiahe Y, Guanghui D, Wenming C, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology 2007; 54: 499-502.

14. Guo W, Xue J, Shi J, Li N, Shao Y, Yu X, Shen F, et al. Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients. J Proteome Res 2010; 9: 4170-5.

15. Fujio K, Hu Z, Evarts RP, Marsden ER, Niu CH, Thorgeirsson SS. Coexpression of stem cell factor and c-kit in embryonic and adult liver. Exp Cell Res 1996; 224: 243-50.

16. Fujio K, Evarts RP, Hu Z, Marsden ER, Thorgeirsson SS. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest 1994; 70: 511-6.

17. Becker FF, Sell S. Differences in serum alpha-fetoprotein concentrations during the carcinogenic sequences resulting from exposure to diethylnitrosamine or acetylaminofluorene. Cancer Res 1979; 39: 1437-42.

18. Fujita N, Aishima S, Iguchi T, Mano Y, Taketomi A, Shirabe K, Honda H, et al. Histologic classification of microscopic portal venous invasion to predict prognosis in hepatocellular carcinoma. Hum Pathol 2011; 42: 1531-8.

19. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244: 898-906.